SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-14-001916
Filing Date
2014-06-16
Accepted
2014-06-16 16:03:07
Documents
5
Period of Report
2012-08-10
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 8-K form8ka.htm 8-K/A 36163
2 EXHIBIT 99.2 ex99-2.htm EX-99.2 409728
3 EXHIBIT 99.3 ex99-3.htm EX-99.3 320495
4 EXHIBIT 99.4 ex99-4.htm EX-99.4 91819
5 EXHIBIT 99.5 ex99-5.htm EX-99.5 141700
  Complete submission text file 0001493152-14-001916.txt   1001047
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-16467 | Film No.: 14922800
SIC: 2834 Pharmaceutical Preparations